Published in J Acquir Immune Defic Syndr Hum Retrovirol on May 01, 1998
Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis (2008) 4.18
Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. Am J Clin Nutr (2011) 2.32
The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr (2009) 2.31
Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr (2010) 2.21
Food insecurity among homeless and marginally housed individuals living with HIV/AIDS in San Francisco. AIDS Behav (2009) 1.91
Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings. Clin Infect Dis (2009) 1.75
Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One (2010) 1.75
Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr (2009) 1.69
User acceptance of HIV TIDES--Tailored Interventions for Management of Depressive Symptoms in persons living with HIV/AIDS. J Am Med Inform Assoc (2007) 1.57
Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med (2002) 1.57
C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting. AIDS (2007) 1.39
Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications. J Gen Intern Med (2011) 1.37
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997. J Am Coll Nutr (2001) 1.18
Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting. Alcohol Clin Exp Res (2007) 1.16
Obesity among HIV-infected persons: impact of weight on CD4 cell count. AIDS (2010) 1.14
Food insecurity and associated factors among HIV-infected individuals receiving highly active antiretroviral therapy in Jimma zone Southwest Ethiopia. Nutr J (2012) 1.07
Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Eur J Epidemiol (2000) 1.04
Low BMI and falling BMI predict HIV-associated tuberculosis: a prospective study in Tanzania. Int J Tuberc Lung Dis (2010) 1.02
Glutamine Analogues As Adjunctive Therapy for Infectious Diarrhea. Curr Infect Dis Rep (2003) 0.96
Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy. PLoS One (2013) 0.95
Disrupted anabolic and catabolic processes may contribute to alcohol-accentuated SAIDS-associated wasting. J Infect Dis (2011) 0.94
Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol (2011) 0.92
Macronutrient supplementation and food prices in HIV treatment. J Nutr (2009) 0.92
Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa. Public Health Nutr (2012) 0.92
Lactation-associated postpartum weight changes among HIV-infected women in Zambia. Int J Epidemiol (2010) 0.91
High risk of obesity and weight gain for HIV-infected uninsured minorities. J Acquir Immune Defic Syndr (2014) 0.89
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. Am J Clin Nutr (2008) 0.87
Predictive value of weight loss on mortality of HIV-positive mothers in a prolonged breastfeeding setting. AIDS Res Hum Retroviruses (2011) 0.84
Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav (2012) 0.83
IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am J Pathol (2004) 0.83
Impact of household food insecurity on the nutritional status and the response to therapeutic feeding of people living with human immunodeficiency virus. Patient Prefer Adherence (2011) 0.83
Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy. Nutr J (2013) 0.80
Relationship of Acute Phase Reactants and Fat Accumulation during Treatment for Tuberculosis. Tuberc Res Treat (2011) 0.80
Prevalence and predictors of HIV among Chinese tuberculosis patients by provider-initiated HIV testing and counselling (PITC): a multisite study in South Central of China. PLoS One (2014) 0.79
Sarcopenia and the analysis of body composition. Adv Nutr (2014) 0.78
Association between chronic hepatitis C virus infection and low muscle mass in US adults. J Viral Hepat (2014) 0.76
Relationship between plasma l-lysine concentrations and levels of HIV-1 RNA. Virulence (2013) 0.75
Development of a nutrient-dense food supplement for HIV-infected women in rural Kenya using qualitative and quantitative research methods. Public Health Nutr (2012) 0.75
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78
Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis (1989) 3.07
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med (1984) 2.93
The pentose cycle, triose phosphate isomerization, and lipogenesis in rat adipose tissue. J Biol Chem (1966) 2.72
A comparison between carboxyhemoglobin and serum thiocyanate determinations as indicators of cigarette smoking. Am J Public Health (1980) 2.62
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48
Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet (1983) 2.30
Persistent diffuse lymphadenopathy in homosexual men: endpoint or prodrome? Ann Intern Med (1984) 2.07
Clinical experience and choice of drug therapy for human immunodeficiency virus disease. Clin Infect Dis (1999) 1.85
Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol (1988) 1.73
Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. Health Soc Work (1998) 1.67
Physician-assisted suicide and patients with human immunodeficiency virus disease. N Engl J Med (1997) 1.64
Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. Am Rev Respir Dis (1991) 1.64
Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet (1982) 1.59
Rilpivirine versus efavirenz in HIV-1-infected subjects receiving emtricitabine/tenofovir DF: pooled 96-week data from ECHO and THRIVE Studies. HIV Clin Trials (2013) 1.53
Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV) J Acquir Immune Defic Syndr (1993) 1.48
AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA (1989) 1.48
Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem (1991) 1.43
Burnout among HIV/AIDS health care providers. Helping the people on the frontlines. AIDS Clin Rev (1992) 1.38
Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis (1987) 1.36
Retracted Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med (1985) 1.36
Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Stat Med (1995) 1.30
Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr (1993) 1.22
Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med (1986) 1.19
Cholesterol, triglyceride, and phospholipid content of intima, media, and atherosclerotic fatty streak in human thoracic aorta. J Clin Invest (1966) 1.19
Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA (1986) 1.17
Estimations of pathway contributions to glucose metabolism and the transaldolase reactions. J Biol Chem (1966) 1.16
Comparison of a computerized and a manual method of food coding for nutrient intake studies. J Am Diet Assoc (1988) 1.14
Method issues in dietary data analyses in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 1.12
Nurses' attitudes and beliefs toward assisted suicide in AIDS. J Assoc Nurses AIDS Care (1998) 1.08
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. J Infect Dis (1989) 1.01
An uncommon Helicobacter isolate from blood: evidence of a group of Helicobacter spp. pathogenic in AIDS patients. J Clin Microbiol (1999) 1.01
AIDS-related lymphadenopathy: the role of biopsy. J Clin Oncol (1986) 1.00
Off-label drug use in human immunodeficiency virus disease. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.00
Genotypic-resistance assays and antiretroviral therapy. Lancet (1997) 1.00
Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J Infect Dis (1984) 0.98
Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.98
Fatty acid composition of human adipose tissue related to age, sex, and race. Am J Clin Nutr (1967) 0.95
A graphical assessment of the potential impact of losses to follow-up on the validity of study results. The Terry Beirn Community Programs for Clinical Research on AIDS. Stat Med (1997) 0.93
Oral viral leukoplakia--a new AIDS-associated condition. Adv Exp Med Biol (1985) 0.93
Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr (2001) 0.92
Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol (1984) 0.92
Fine-needle aspiration cytology of lymphadenopathy in homosexual males. Diagn Cytopathol (1986) 0.90
Effects of the use of AZT on the medical care costs of persons with AIDS in the first 12 months. J Acquir Immune Defic Syndr (1990) 0.90
Immunodeficiency-associated thrombocytopenic purpura (IDTP). Response to splenectomy. Arch Surg (1987) 0.88
A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group. Control Clin Trials (1991) 0.88
Routine care and psychosocial support of the patient with the acquired immunodeficiency syndrome. Med Clin North Am (1986) 0.86
A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab (1996) 0.86
Dietary intake in the Multiple Risk Factor Intervention Trial (MRFIT): nutrient and food group changes over 6 years. J Am Diet Assoc (1986) 0.86
The usefulness of diagnostic bone marrow examination in patients with human immunodeficiency virus (HIV) infection. J Acquir Immune Defic Syndr (1991) 0.85
Pathways of acetoacetate's formation in liver and kidney. J Biol Chem (1982) 0.84
Associations between water-treatment methods and diarrhoea in HIV-positive individuals. Epidemiol Infect (2002) 0.84
Alternative therapies in HIV infection. AIDS (1990) 0.83
Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol (1987) 0.83
Risk factors for rapid progression from hairy leukoplakia to AIDS: a nested case-control study. J Acquir Immune Defic Syndr (1991) 0.83
Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.81
Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 0.81
Disseminated coccidioidomycosis in AIDS. N Engl J Med (1984) 0.81
Estimation of the glucuronic acid pathway contribution to glucose metabolism in adipose tissue and the effect of growth hormone. J Biol Chem (1966) 0.80
Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol (1986) 0.80
Lymphadenopathy related to the acquired immunodeficiency syndrome in homosexual men. Med Clin North Am (1986) 0.79
Lack of response to suramin in patients with AIDS and AIDS-related complex. Am J Med (1987) 0.79
AIDS-related benign lymphadenopathy and malignant lymphoma: clinical aspects and virologic interactions. AIDS Res (1986) 0.79
Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. AIDS (1998) 0.78
Lymphadenopathy: end-point prodrome? Update of a 36-month prospective study. Adv Exp Med Biol (1985) 0.78
Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.77
A method for quantitating the contributions of the pathways of acetoacetate formation and its application to diabetic ketosis in vivo. J Biol Chem (1982) 0.77
Kaposi sarcoma and lymphadenopathy syndrome: limitations of abdominal CT in acquired immunodeficiency syndrome. Radiology (1984) 0.77
Lymphadenopathy: endpoint or prodrome? Update of a 24-month prospective study. Ann N Y Acad Sci (1984) 0.77
AIDS in the "gay" areas of San Francisco. Lancet (1983) 0.77
Hormonal regulation of glucose metabolism in adipose tissue in vitro. Ann N Y Acad Sci (1965) 0.77
Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trial. J Acquir Immune Defic Syndr (1989) 0.77
Cat scratch disease and acquired immunodeficiency disease: diagnosis by transmission electron microscopy. Ultrastruct Pathol (1997) 0.77
Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection. HIV Med (2014) 0.77
Randomized, controlled trial of caloric supplements in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr (1999) 0.76
A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complex. Biotechnol Ther (1993) 0.76
Emergency department time for evaluation of patients discharged with a diagnosis of renal colic: unenhanced helical computed tomography versus intravenous urography. J Emerg Med (2001) 0.76
The role of critical care nurses in euthanasia and assisted suicide. N Engl J Med (1996) 0.75
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group. Clin Infect Dis (1993) 0.75
Abdominal CT in acquired immunodeficiency syndrome. AJR Am J Roentgenol (1986) 0.75
Food group and nutrient intakes at baseline in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 0.75
Not all is dead in HIV-1 graveyard. Lancet (1998) 0.75
Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura. Am J Hematol (1991) 0.75
Quality control in the MRFIT local screening and clinic laboratory. Control Clin Trials (1986) 0.75
HLA class I and II antigen phenotypes of North American Indians from Minnesota: implications for marrow transplants using unrelated donors. Transfusion (1990) 0.75
Food group and macronutrient intakes, trial years 1-6, in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 0.75
AIDS-related lymphomas: evaluation by abdominal CT. Radiology (1986) 0.75
Relation of dietary fiber to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 0.75
Racial and ethnic modifiers of the salt-blood pressure response. Hypertension (1991) 0.75
The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a national marrow donor program involving multiple centers. Tissue Antigens (1993) 0.75
Urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in mild hypertension. Am J Hypertens (1994) 0.75
Relation of dietary carbohydrates to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 0.75
Disseminated toxoplasmosis and acquired immunodeficiency syndrome: diagnosis by transmission electron microscopy. Ultrastruct Pathol (1995) 0.75
Informational needs of homosexual men diagnosed with AIDS or AIDS-related complex. Oncol Nurs Forum (1988) 0.75
Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS. Clin Infect Dis (1993) 0.75